Porto, Portugal (ots/PRNewswire) - Abstract# RS3:3 Today, results from a post hoc analysis of data from the SCALE Maintenance trial were presented at the 24th European Congress on Obesity (ECO) 2017. In the trial, adults who lost at least 5% of their initial weight during a low- calorie run-in period were randomised ...
Calgary, Alberta (ots/PRNewswire) - Apabetalone expands to a second major clinical indication in kidney dialysis patients Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce the acceptance, by the Cardiovascular and Renal Products Division of the U.S. Food and Drug Administration ...
Sunnyvale, California (ots/PRNewswire) - Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control with Reduced Toxicities Accuray Incorporated (NASDAQ: ARAY) announced today that studies continue to demonstrate the unmatched flexibility of the cutting-edge TomoTherapy® System to treat, with ...
Sunnyvale, California (ots/PRNewswire) - Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease Accuray Incorporated (NASDAQ: ARAY) announced today that studies on the clinical use of the leading-edge CyberKnife® System ...
Toronto and Amsterdam (ots/PRNewswire) - - Norgine to acquire all outstanding shares of Merus for $1.65 per share in cash Merus Labs International Inc. ("Merus" or the "Company") TSX: MSL, NASDAQ: MSLI and Norgine B.V. ("Norgine") announced today that they have entered into a definitive agreement (the "Arrangement Agreement") under which Norgine will acquire all of the issued and outstanding common shares of Merus for ...
Vista, California (ots/PRNewswire) - The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite(TM) Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - With this approval, Pergoveris® becomes the first product with a combination of FSH and LH hormones in a ready-to-use liquid version - The new pre-filled injection device for self-administration increases ease-of-use for patients ...
Aachen, Germany (ots) - - Grünenthal's new Innovation Hub in Greater Boston, U.S., shall accelerate easier access to and close collaboration with leading scientists and institutions - Grünenthal brings fully integrated R&D capabilities in pain to this community - there is no other company with so much focus on ...
Darmstadt, Germany, and New York (ots/PRNewswire) - - Second approval for BAVENCIO in less than two months - Advanced urothelial carcinoma is an aggressive disease with a high rate of recurrence Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) Injection for the treatment of patients with ...
Basel, Switzerland, Lausanne, Switzerland and Helsinki, Finland (ots) - Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today ...
Boston and Rijswijk, Netherlands (ots/PRNewswire) - Bluebee Holding BV, a leading provider of high performance genomics solutions, today announced the appointment of two new members to its Board of Directors. Lars Kongsbak has been appointed as an independent director, and Nicolas Roelofs will become Chairman of the Board. About Nicolas H Roelofs An Industrial Advisor with Nordic Capital LTD, he has gained significant ...
Amsterdam (ots/PRNewswire) - - Introduces RTdrive*, an automated workflow solution that streamlines the planning process from MR imaging to the treatment plan, saving time and increasing consistency. - Highlights MR and CT simulation along with the newly updated Pinnacle3 16 treatment planning system, to deliver ...
Sunnyvale, California (ots/PRNewswire) - Innovations in Hardware and Software Solutions Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases Accuray Incorporated (NASDAQ: ARAY) announced today that the company will highlight its portfolio of radiation therapy delivery systems and software solutions at the annual European Society for ...
Sunnyvale, California (ots/PRNewswire) - Robotic Radiosurgery System's Unique Motion Management Technique Limits Toxicity and Preserves Cosmesis in Convenient, 5-Fraction Treatment Regimen Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase I clinical trial evaluating ...
Lund, Sweden and Princeton, New Jersey (ots/PRNewswire) - New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients with opioid use disorder Camurus (NASDAQ STO: CAMX) and Braeburn Pharmaceuticals today announced positive top-line results from a long-term ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts and Durham, North Carolina (ots/PRNewswire) - Demonstrates ongoing commitment to innovation in ophthalmics for Shire P-321 is a Phase 2 investigational topical treatment for dry eye disease Shire plc (LSE: SHP, NASDAQ: SHPG) and Parion Sciences, Inc. today announced they have entered into an ...
Darmstadt, Germany (ots/PRNewswire) - - Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo Merck, a leading science and technology company, announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in ...
Munich (ots/PRNewswire) - - ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation - Study adds to the growing Edoxaban Clinical Research Programme (ECRP) ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Natpar is the first and only licensed recombinant human parathyroid hormone therapy for chronic hypoparathyroidism Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the European Commission (EC) has granted Conditional Marketing Authorisation for Natpar (rhPTH[1-84]), the ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Shire launches campaign to raise global awareness during World PI Week Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung heroes who make a difference in the lives of people living with primary immunodeficiency (PI). PI is a group of nearly ...
Vienna (ots/PRNewswire) - CDI, a potentially fatal disease,[2] is three times as deadly as MRSA[3],[4] and is estimated to cost the EU EUR3 billion per annum[5] New data presented today at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, demonstrate benefits of ...
Darmstadt, Germany (ots/PRNewswire) - - Breadth of data and activities underscore company's long-standing commitment to enhancing care for people with MS Merck, a leading science and technology company, will present data at the American Academy of Neurology (AAN) 69th Annual Meeting, taking place from April 22-28, ...
Vienna (ots/PRNewswire) - CDI is one of the top ten hospital-acquired infections (HAIs) in European Hospitals[1] and is estimated to be three times as deadly as MRSA[2],[3] Data released at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017 demonstrate the impact of CDI on the ...
Haifa, Israel (ots/PRNewswire) - INSIGHTEC (https://goo.gl/knr17E) congratulates Nicklaus Children's Hospital (https://www.nicklauschildrens.org/home), part of the Miami Children's Health System, for performing the first focused ultrasound procedure on a 21-year old patient suffering seizures associated with a ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - On World Hemophilia Day 2017, Shire challenges the community to collectively improve global standards of care for rare bleeding disorders Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company focused on serving individuals with rare diseases, joins the global ...
Sunnyvale, California (ots/PRNewswire) - Premier Algerian Cancer Center Now Provides Cancer Patients with Leading-Edge Radiation Treatments Accuray Incorporated (NASDAQ: ARAY) announced today that the newly built Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria is now treating cancer patients with the first TomoTherapy® Systems installed in Africa. ...
Venlo the Netherlands (ots) - QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) has posted its 2016 Annual Report on its website at http://ots.de/YwER5. QIAGEN's Annual Report on Form 20-F for the year ended December 31, 2016 has been filed with the U.S. Securities and Exchange Commission (SEC) on March 3, 2017, a copy of which can be found on the website of the SEC at www.sec.gov or in the 'Financial Information' section of ...
Sunnyvale, California (ots/PRNewswire) - Partnership Creates Strategic Alliance for Clinical Education and Training in Robotic Radiosurgery Accuray Incorporated (NASDAQ: ARAY) announced today the signing of a three-year Collaboration and Support Agreement with the N.N. Burdenko National Scientific and Practical ...
Royal Philips and B. Braun Melsungen AG
Melsungen, Germany and Amsterdam (ots/PRNewswire) - - Strategic alliance combines B. Braun's leadership in regional anesthesia and Philips' leadership in image guided therapy solutions with the aim to make regional anesthesia and vascular access easier to perform, leading to enhanced patient care and hospital ...
Orlando, Florida (ots/PRNewswire) - Abstract #620 Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin, exenatide extended release (ER) and insulin glargine U100 in adults with ...